Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
cal-1 modified cd4+ t lymphocytes (1 trial)
cal-1 modified hspc (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
HIV Infections (Phase 2)
Trials (1 total)
Trial APIs (2 total)